one-Cylopropanoyl-LSD (1CP-LSD) has not long ago emerged as a fresh addition for the growing range of lysergamide-dependent designer prescription drugs. It appears to are already absent within the scientific literature, which induced the present investigation to disseminate critical analytical facts